Pilot trial of a novel two-step therapy protocol using nebulized tranexamic acid and recombinant factor VIIa in children with intractable diffuse alveolar hemorrhage

BACKGROUND AND OBJECTIVES: Diffuse alveolar hemorrhage (DAH) is a life threatening condition with very limited, often unsuccessful, therapeutic options. This study aimed at exploring the feasibility and efficacy of nebulized tranexamic acid TXA (n-TXA) and nebulized recombinant factor VIIa (n-rFVIIa...

Descripción completa

Detalles Bibliográficos
Autores principales: Bafaqih, Hind, Chehab, May, Almohaimeed, Suliman, Thabet, Farah, Alhejaily, Abdulrahman, AlShahrani, Mohammed, Zolaly, Mohammed A., Abdelmoneim, Abeer A., Abd El-Moneim, Ehab S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: King Faisal Specialist Hospital and Research Centre 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074453/
https://www.ncbi.nlm.nih.gov/pubmed/26409798
http://dx.doi.org/10.5144/0256-4947.2015.231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074453/
https://www.ncbi.nlm.nih.gov/pubmed/26409798
http://dx.doi.org/10.5144/0256-4947.2015.231

Ejemplares similares